01 Procurement
Tender overview
- Buyer
- Cardiff University
- Status
- Complete
- Procurement method
- Direct award
- Category
- Not supplied
- CPV classification
- Not supplied
- Tender period
- Not supplied — Not supplied
Description
The B&M Gates Foundation (funder) have reviewed the work with the EMBED research team, undertaken with the manufacturer ProMed, and have decided that to push the EMBED 3.0 project into its next stage (EMBED 4.0 – Human Trials), they’ll need to demonstrate their ability to vary the additional batches offer a more robust mechanism for the medications to enter patients. The additional work has been again funded by the foundation for the purpose of increasing the viability of the delivery method (technology developed as part of EMBED) - Previous direct award for the initial development via Regulation 41 - Schedule 5, para 2.
This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.
02 Awards and contracts
Published award records
EMBED 3.0 – Improvement of Formulations
- Awarded
- Not supplied
- Award value
- £187,587
- Suppliers
- 1
- Signed contract
- Not supplied
03 Organisations
Buyers, suppliers and other parties
Cardiff University
Procurement Services, Cardiff, UKL22, CF24 4HQ, United Kingdom
GB-PPON PHVT-4343-HWYRProMed Pharma, LLC
6765 Wedgwood Road, Maple Grove, MN 55311 USA, Minneapolis, US, MN 55311, United States
GB-PPON PRNX-3276-XWMGCompanies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.
04 Provenance
Source for this process
Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.